UA117908C2 - Застосування гепарину або гепарансульфату для індукції пологів - Google Patents

Застосування гепарину або гепарансульфату для індукції пологів

Info

Publication number
UA117908C2
UA117908C2 UAA201411546A UAA201411546A UA117908C2 UA 117908 C2 UA117908 C2 UA 117908C2 UA A201411546 A UAA201411546 A UA A201411546A UA A201411546 A UAA201411546 A UA A201411546A UA 117908 C2 UA117908 C2 UA 117908C2
Authority
UA
Ukraine
Prior art keywords
combination treatment
inducing labor
sulphated glycosaminoglycans
glycosaminoglycans
inducing
Prior art date
Application number
UAA201411546A
Other languages
English (en)
Inventor
Ґунвор Екман-Ордеберг
Андерс Мальмстрьом Мальмстрьом
Original Assignee
Ділафор Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ділафор Аб filed Critical Ділафор Аб
Publication of UA117908C2 publication Critical patent/UA117908C2/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727Heparin; Heparan
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/095Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Винахід стосується застосування сульфатованих глікозаміногліканів в комбінації з простагландином або окситоцином для індукції пологів.
UAA201411546A 2012-03-26 2013-03-25 Застосування гепарину або гепарансульфату для індукції пологів UA117908C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261615398P 2012-03-26 2012-03-26
PCT/SE2013/050332 WO2013147689A1 (en) 2012-03-26 2013-03-25 Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Publications (1)

Publication Number Publication Date
UA117908C2 true UA117908C2 (uk) 2018-10-25

Family

ID=49260783

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201411546A UA117908C2 (uk) 2012-03-26 2013-03-25 Застосування гепарину або гепарансульфату для індукції пологів

Country Status (15)

Country Link
US (1) US20150045322A1 (uk)
EP (1) EP2830635A4 (uk)
JP (1) JP6234989B2 (uk)
CN (1) CN104203256B (uk)
AU (1) AU2013240597A1 (uk)
CA (1) CA2868444A1 (uk)
HK (1) HK1203369A1 (uk)
IL (1) IL234689A0 (uk)
MX (1) MX2014011505A (uk)
MY (1) MY175743A (uk)
RU (1) RU2014143017A (uk)
SG (1) SG11201406119WA (uk)
UA (1) UA117908C2 (uk)
WO (1) WO2013147689A1 (uk)
ZA (1) ZA201406901B (uk)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104144950B (zh) 2011-12-19 2017-09-05 迪乐方有限责任公司 含有重复的二糖单元的非抗凝的葡糖胺聚糖及其医药用途
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
CA2868403A1 (en) * 2012-05-08 2013-11-14 Dilafor Ab Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
JP2023512920A (ja) 2020-02-17 2023-03-30 ディラフォール アクチエボラグ 子癇前症の処置のためのタフォキシパリン
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin
AR129190A1 (es) 2022-05-03 2024-07-31 Dilafor Ab Nuevo uso médico de la tafoxiparina

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5993810A (en) * 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US8445436B2 (en) * 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
WO2013081896A1 (en) * 2011-11-28 2013-06-06 Corning Incorporated Robust optical touch-screen systems and methods using a planar transparent sheet
CN104144950B (zh) * 2011-12-19 2017-09-05 迪乐方有限责任公司 含有重复的二糖单元的非抗凝的葡糖胺聚糖及其医药用途

Also Published As

Publication number Publication date
HK1203369A1 (en) 2015-10-30
RU2014143017A (ru) 2016-05-20
SG11201406119WA (en) 2014-11-27
US20150045322A1 (en) 2015-02-12
IL234689A0 (en) 2014-11-30
CN104203256A (zh) 2014-12-10
ZA201406901B (en) 2017-09-27
CN104203256B (zh) 2017-11-24
WO2013147689A1 (en) 2013-10-03
EP2830635A1 (en) 2015-02-04
AU2013240597A1 (en) 2014-10-16
MY175743A (en) 2020-07-07
JP2015511664A (ja) 2015-04-20
CA2868444A1 (en) 2013-10-03
EP2830635A4 (en) 2016-03-16
JP6234989B2 (ja) 2017-11-22
MX2014011505A (es) 2014-12-05

Similar Documents

Publication Publication Date Title
GB201517215D0 (en) Use of cannabinoids in the treatment of inflammatory skin diseases
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
PH12016501139A1 (en) Bicyclic heterocycle compounds and their uses in therapy
EA201500314A1 (ru) Лекарственные формы энзалутамида
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
HK1213192A1 (zh) 用於在人類受試者中治療眼部疾病的方法和裝置
SG11201602070TA (en) Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
MX2019011825A (es) Tratamiento de enfermedades inflamatorias con inhibidores de actividad de c5a.
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
EA201590115A8 (ru) Внеклеточная днк в качестве терапевтической мишени для бесплодия у особи женского пола и диагностического маркера
MY175743A (en) Combination treatment comprising sulphated glycosaminoglycans for inducing labor
IL249580A0 (en) Methods for anesthetizing nerve tissue in the trigeminal nerve pathway and their medical uses
MY185108A (en) Method for treatment of labor arrest
EP3380088A4 (en) USE OF MICROARN-146A AND A CONJUGATE OF CERIUM OXIDE NANOPARTICLES TO IMPROVE HEALING AND PROMOTE TISSUE REGENERATION
IL245738A0 (en) Oxindole derivatives, ways of their preparation and their therapeutic use in the treatment of ampk-related diseases
PH12015500663A1 (en) Pharmaceutical combinations comprising dual angiopoietin-2/dll4 binders and anti-vegf-r agents
NZ729181A (en) Treatment of disease with poly-n-acetylglucosamine nanofibers
IN2014MN02461A (uk)
MY192330A (en) Treatment of postpartum haemorrhage with chemically modified heapin or heparan sulphate and a uterotonic agent
EP2943593A4 (en) DIAGNOSIS AND TREATMENT OF VIRUS DISEASES
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
EP2827951A4 (en) COMBINATION THERAPY TO IMPROVE THE HEALING OF JOINTS, TIGHTS AND TAPES
HK1209073A1 (en) Plod-2 stimulators and their use in the treatment of skin plod-2
LT3052476T (lt) Pakeisti nikotinimido btk inhibitoriai ir jų preparatai bei naudojimas vėžio, uždegimo ir autoimuninės ligos gydymui
SI3160437T1 (sl) Sestavek ustrezen za preprečevanje fiziološkega stanja kože in las in ponovna vzpostavitev njunih regenerativnih funkcij